Hello Sirs,
I've been writing to Cosmopharma for an update about Cosmo - CB-03-01 and that's their answer:
Dear Mr. xxx,
I am glad to inform you that Phase II US clinical study on acne vulgaris (NCT01631474) started as planned on June 2012, and it is proceeding regularly.
A previous Phase II European study in facial acne vulgaris (EudraCT 2008-004335-37) was completed in July 2009, and the results have been published on British Medical Journal 2011;165:177-83.
As concerns the possible US launch, we maintain our deadline for 2015.
Kind regards
Giuseppe Celasco, MD
Chief Medical Officer
This is a positive news cause we know that the molecule for acne and hair is the same.
I hope it helps
I've been writing to Cosmopharma for an update about Cosmo - CB-03-01 and that's their answer:
Dear Mr. xxx,
I am glad to inform you that Phase II US clinical study on acne vulgaris (NCT01631474) started as planned on June 2012, and it is proceeding regularly.
A previous Phase II European study in facial acne vulgaris (EudraCT 2008-004335-37) was completed in July 2009, and the results have been published on British Medical Journal 2011;165:177-83.
As concerns the possible US launch, we maintain our deadline for 2015.
Kind regards
Giuseppe Celasco, MD
Chief Medical Officer
This is a positive news cause we know that the molecule for acne and hair is the same.
I hope it helps